Eligibility Rheumatoid Arthritis NCT00650078

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented history of ra in agreement with acr criteria
Beschreibung

Rheumatoid Arthritis

Datentyp

boolean

Alias
UMLS CUI [1]
C0003873
dmard treatment for ra greater than or equal to 6 months, with a stable dose greater than or equal to 6 weeks prior to screening visit
Beschreibung

DMARD Dose Stable Rheumatoid Arthritis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0242708
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0003873
duration of morning stiffness greater than or equal to 45 minutes
Beschreibung

Morning stiffness Duration

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0457086
UMLS CUI [1,2]
C0449238
greater than or equal to 4 swollen joints (out of 28)
Beschreibung

Swollen joint count

Datentyp

boolean

Alias
UMLS CUI [1]
C0451521
greater than or equal to 4 tender joints (out of 28)
Beschreibung

Tender joint count

Datentyp

boolean

Alias
UMLS CUI [1]
C0451530
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
suffering from another disease, which requires glucocorticoid treatment during the study period
Beschreibung

ID.6

Datentyp

boolean

synovectomy within 4 months prior to study start
Beschreibung

Synovectomy

Datentyp

boolean

Alias
UMLS CUI [1]
C0185304
use of glucocorticoids:
Beschreibung

Glucocorticoids

Datentyp

boolean

Alias
UMLS CUI [1]
C0017710
continued use of systemic glucocorticoids within 4 weeks prior to screening visit
Beschreibung

Glucocorticoids, Systemic

Datentyp

boolean

Alias
UMLS CUI [1]
C3540777
intermittent use of glucocorticoids within 2 weeks prior to screening visit.
Beschreibung

Glucocorticoids Intermittent administration

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0017710
UMLS CUI [1,2]
C0444735
joint injections within 6 weeks prior to screening visit
Beschreibung

Joint injection

Datentyp

boolean

Alias
UMLS CUI [1]
C0848063
topical glucocorticoids must be stopped at screening visit
Beschreibung

Topical glucocorticoid To be stopped

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0017712
UMLS CUI [1,2]
C1272691
use of biologicals such as: tumor necrosis factor α (tnfα) inhibitors and other compounds within 5 serum half lives prior to screening visit
Beschreibung

Biological agents | Tumor necrosis factor alpha (TNF-) inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C0005515
UMLS CUI [2]
C3653350
pregnancy or nursing
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Ähnliche Modelle

Eligibility Rheumatoid Arthritis NCT00650078

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Rheumatoid Arthritis
Item
documented history of ra in agreement with acr criteria
boolean
C0003873 (UMLS CUI [1])
DMARD Dose Stable Rheumatoid Arthritis
Item
dmard treatment for ra greater than or equal to 6 months, with a stable dose greater than or equal to 6 weeks prior to screening visit
boolean
C0242708 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003873 (UMLS CUI [1,4])
Morning stiffness Duration
Item
duration of morning stiffness greater than or equal to 45 minutes
boolean
C0457086 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Swollen joint count
Item
greater than or equal to 4 swollen joints (out of 28)
boolean
C0451521 (UMLS CUI [1])
Tender joint count
Item
greater than or equal to 4 tender joints (out of 28)
boolean
C0451530 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.6
Item
suffering from another disease, which requires glucocorticoid treatment during the study period
boolean
Synovectomy
Item
synovectomy within 4 months prior to study start
boolean
C0185304 (UMLS CUI [1])
Glucocorticoids
Item
use of glucocorticoids:
boolean
C0017710 (UMLS CUI [1])
Glucocorticoids, Systemic
Item
continued use of systemic glucocorticoids within 4 weeks prior to screening visit
boolean
C3540777 (UMLS CUI [1])
Glucocorticoids Intermittent administration
Item
intermittent use of glucocorticoids within 2 weeks prior to screening visit.
boolean
C0017710 (UMLS CUI [1,1])
C0444735 (UMLS CUI [1,2])
Joint injection
Item
joint injections within 6 weeks prior to screening visit
boolean
C0848063 (UMLS CUI [1])
Topical glucocorticoid To be stopped
Item
topical glucocorticoids must be stopped at screening visit
boolean
C0017712 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
Biological agents | Tumor necrosis factor alpha (TNF-) inhibitors
Item
use of biologicals such as: tumor necrosis factor α (tnfα) inhibitors and other compounds within 5 serum half lives prior to screening visit
boolean
C0005515 (UMLS CUI [1])
C3653350 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])